Activists in Berlin stage picket condemning Obama’s foreign policyWorld January 19, 21:17
Russian regulator promises to respond to any US restrictions of RT channelRussian Politics & Diplomacy January 19, 21:09
FIFA: Over 82,400 ticket requests applied globally for 2017 Confederations Cup in RussiaSport January 19, 20:17
Russia stands for developing legal tool to fight cyber hooliganismRussian Politics & Diplomacy January 19, 20:00
Russia is developing advanced hypersonic weapons — ministryMilitary & Defense January 19, 19:50
Former USSR leader receives Lithuanian court’s summons as witness in case over 1991 eventsWorld January 19, 19:29
FIDE chief says he plans to seek US entry after President-elect Trump’s inaugurationSport January 19, 18:56
Russian economy minister: Results of 2016 demonstrated adjustment to cheap oil, sanctionsBusiness & Economy January 19, 18:44
Russia ready to welcome Trump at economic forum in St. Petersburg — first deputy PMBusiness & Economy January 19, 18:29
MOSCOW, October 29. /TASS/. The Federal Antimonopoly Service (FAS) wants to introduce a simplified procedure for admission of medicines, previously registered in the US and Europe to Russia, the head of FAS Igor Artemyev said on Thursday speaking at a cabinet session.
"It is necessary to check the history [of these medicines]. This system should not be automatic, we have to check, but if it was registered in the United States or Europe, there must be a simplified procedure for the introduction of these medicines in the Russian Federation," he said.
Artemyev also said that in the next five years a new section for the development of competition in the healthcare sector should be added to the competition development program.
"It is necessary to add an aspect about the sale of medicines via retail chains there. I would say that the issue of substitution should be solved not by 2018 but by 2017. This will have a significant effect on prices and improve competition in healthcare sector," he said.